每年研究成果
每年研究成果
搜尋結果
-
The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy
Su, P. L., Chen, J. Y., Chu, C. Y., Chen, Y. L., Chen, W. L., Lin, K. Y., Ho, C. L., Tsai, J. S., Yang, S. C., Chen, C. W., Wu, Y. L., Tseng, Y. L., Chang, C. C., Yen, Y. T., Lin, C. Y., Lin, C. C. & Su, W. C., 2022 12月, 於: Scientific reports. 12, 1, 3319.研究成果: Article › 同行評審
開啟存取4 引文 斯高帕斯（Scopus） -
Improved survival in patients with unresectable stage III EGFR-mutant adenocarcinoma with upfront EGFR-tyrosine kinase inhibitors
Wang, S. Y., Lai, C. H., Chen, C. W., Yang, S. C., Chang, C. C., Lin, C. Y., Yen, Y. T., Tseng, Y. L., Su, P. L., Lin, C. C. & Su, W. C., 2022 1月, 於: Thoracic Cancer. 13, 2, p. 182-189 8 p.研究成果: Article › 同行評審
開啟存取1 引文 斯高帕斯（Scopus） -
First-line treatment with irreversible tyrosine kinase inhibitors associated with longer OS in EGFR mutation-positive non-small cell lung cancer
Su, P. L., Chen, C. W., Wu, Y. L., Lin, C. C. & Su, W. C., 2021 2月, 於: Thoracic Cancer. 12, 3, p. 287-296 10 p.研究成果: Article › 同行評審
開啟存取3 引文 斯高帕斯（Scopus） -
Development and validation of a prediction index for recent mortality in advanced COPD patients
Tsai, S. H., Shih, C. Y., Kuo, C. W., Liao, X. M., Lin, P. C., Chen, C. W., Hsiue, T. R. & Chen, C. Z., 2022 12月, 於: npj Primary Care Respiratory Medicine. 32, 1, 2.研究成果: Article › 同行評審
開啟存取 -
Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study
Huang, T. H., Kuo, C. W., Chen, C. W., Tseng, Y. L., Wu, C. L. & Lin, S. H., 2021 12月, 於: BMC Pulmonary Medicine. 21, 1, 165.研究成果: Article › 同行評審
開啟存取4 引文 斯高帕斯（Scopus）